REPL
Replimune Group, Inc. · Healthcare
Chief Accounting Officer Andrew Schwendenman sold $99K of Replimune Group, Inc.
Sold$98,987
$12.97Price
7,632Shares
−7%Stake
What REPL did after the filing
- The stock from Thu, Aug 13 open, $15.00
- −16.3%
- S&P 500, same days
- −1.2%
Measured over 30 trading days, to the Sep 28 close.
Traded Mon, Aug 10. Filed Wed, Aug 12, 5:04 PM ET, after the close. Returns use the Aug 13 open and the Sep 28 close. Not investment advice.